ПРЕКОНДИЦИОНИРОВАНИЕ КАК НОВЫЙ СПОСОБ ПОВЫШЕНИЯ ТЕРАПЕВТИЧЕСКОЙ ЭФФЕКТИВНОСТИ МЕЗЕНХИМАЛЬНЫХ СТВОЛОВЫХ КЛЕТОК

1. Short B., Brouard N., Occhiodoro-Scott T., Ramakrishnan A., Simmons P.J. Mesenchymal stem cells // Arch Med Res. - 2003. - № 34 - Р. 565-571.

2. Hass R., Kasper C., Bohm S., Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC // Cell Commun Signal. - 2011. - № 9 - Р. 12.

3. Wang Y., Chen X., Cao W., Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications // Nat Immunol. - 2014. - № 15 (11) - Р. 1009-1016.

4. Kokabu S., Lowery J.W., Jimi E. Cell fate and differentiation of bone marrow mesenchymal stem cells // Stem Cells Int. - 2016. - № 2016 - Р. 3753581.

5. Saparov A., Ogay V., Nurgozhin T., Jumabay M., Chen W.C. Preconditioning of human mesenchymal stem cells to enhance their regulation of the immune response // Stem Cells Int. - 2016. - № 2016 - Р. 3924858.

6. Ylostalo J.H., Bartosh T.J., Coble K., Prockop D.J. Human mesenchymal stem/stromal cells cultured as spheroids are selfactivated to produce prostaglandin Е2 that directs stimulated macrophages into an anti-inflammatory phenotype // Stem Cells. - 2012. - Vol. 30, № 10 - Р. 2283-2296.

7. Zimmermann J.A., Mcdevitt T.C. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion // Cytotherapy. - 2014. - Vol. 16, № 3 - Р. 331-345.